Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)
A Longitudinal Study of Orbital and Cranial Vessel Wall MRI in Giant Cell Arteritis by the Vascular MRI Evaluation in Giant Cell Arteritis (VEGA) Collaborative
University of Pennsylvania
400 participants
Jul 29, 2020
OBSERVATIONAL
Conditions
Summary
The research study is being conducted to determine the utility of magnetic resonance imaging (MRI) in identifying inflammation of arteries supplying blood to the head, brain, and eyes. The target population includes patient with suspected giant cell arteritis (GCA; temporal arteritis).
Eligibility
Inclusion Criteria5
- Age 50 years or older
- First presentation of suspected GCA
- New or worsening cranial manifestations within 4 weeks of enrollment concerning for active GCA
- Elevated CRP greater than 1.0 mg/dl
- Plan to undergo temporal artery biopsy or ultrasound for diagnosis
Exclusion Criteria3
- Contra-indication to receiving MRI including:
- Implanted medical devices, pacemaker, and metallic foreign fragments inside body/orbits Known gadolinium allergy Women who are pregnant or nursing
- Absence of cranial symptoms related to GCA (e.g., only large vessel GCA)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Combined orbital and cranial vessel wall MRI
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05865054